129 related articles for article (PubMed ID: 2474641)
1. Effect of 8-hexyloxy-3-(1H-tetrazol-5-yl)-2H-chromen-2-one [KP-136] on experimental asthma: a comparison with disodium cromoglycate.
Kuriyama K; Hiyama Y; Ito K
J Pharmacobiodyn; 1989 Mar; 12(3):175-81. PubMed ID: 2474641
[TBL] [Abstract][Full Text] [Related]
2. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
Kuriyama K; Hiyama Y; Ito K
Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289
[TBL] [Abstract][Full Text] [Related]
4. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
5. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
Revel L; Colombo S; Ferrari F; Folco G; Rovati LC; Makovec F
Eur J Pharmacol; 1992 Dec; 229(1):45-53. PubMed ID: 1282105
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of a new antiallergic agent, KP-136 on mast cell activation: a comparison with disodium cromoglycate.
Kuriyama K; Hiyama Y; Ito K; Yoshinaka I; Bito Y
Agents Actions; 1988 Dec; 25(3-4):321-5. PubMed ID: 3146215
[TBL] [Abstract][Full Text] [Related]
7. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
Terasawa M; Imayoshi T; Goto K
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
[TBL] [Abstract][Full Text] [Related]
8. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
9. Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs.
Goto K; Terasawa M; Kadobe Y; Maruyama Y
Jpn J Pharmacol; 1980 Aug; 30(4):537-47. PubMed ID: 6162988
[TBL] [Abstract][Full Text] [Related]
10. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological actions of oxatomide (KW-4354). 3. Actions on experimental asthma and Schultz-Dale reaction].
Ohmori K; Ishii H; Takei Y; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):481-93. PubMed ID: 6131021
[TBL] [Abstract][Full Text] [Related]
12. Dual modes of action for disodium cromoglycate in inhibition of antigen-induced contractions of guinea-pig isolated airways smooth muscle.
Stewart AG; Fennessy MR
Clin Exp Pharmacol Physiol; 1983; 10(5):595-603. PubMed ID: 6416724
[TBL] [Abstract][Full Text] [Related]
13. [Antiallergic effects of mequitazine. 2. In vivo experiments].
Kohno S; Yamamura H; Ohata K; Togawa M; Nagai H; Koda A; Yanagihara Y; Shida T; Yatsuzuka A; Yoshida Y
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):159-65. PubMed ID: 2906316
[TBL] [Abstract][Full Text] [Related]
14. An antiallergic activity of disodium cromoglycate unrelated to mast cell activation.
Kuriyama K; Hiyama Y; Nagatahira R; Okuda T; Saito K; Ito K
Agents Actions; 1986 Aug; 18(5-6):473-8. PubMed ID: 2429526
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
Kuriyama K; Hiyama Y; Ito K; Ichikawa K; Kitada S; Yoshinaka I
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):213-24. PubMed ID: 2440785
[TBL] [Abstract][Full Text] [Related]
16. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
Khandwala A; Dally-Meade V; Jariwala N; Huang F
Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
[TBL] [Abstract][Full Text] [Related]
17. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
Yanagihara Y; Kasai H; Matsui S; Ninomiya K
Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743
[TBL] [Abstract][Full Text] [Related]
18. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
[TBL] [Abstract][Full Text] [Related]
19. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
20. Antiallergic activity of tiaramide (RHC 2592-A).
Khandwala A; Coutts S; Weinryb I
Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
